How Viagra Made Pfizer Billions Before Generics

From the creator

Pfizer was making $1.8 billion a year on average from Viagra when the erectile dysfunction drug first appeared on the market. After the patent expired in late 2017 and competitors created cheaper alternatives and generics, Viagra sales plummeted with 73% year-over-year for 2018. Pfizer still holds the lead in the erectile dysfunction market with 65% even as Viagra sales falter. It’s been able to maintain that significant share thanks in part to launching Sildenafil, its own generic version of the blue, diamond-shaped pill. Cialis and its generic, Tadalafil, and Levitra and its generic, Vardenafil, are close behind with 30% and 5% of market share, respectively. » Subscribe to CNBC: http://cnb.cx/SubscribeCNBC » Subscribe to CNBC TV: http://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC Classic: http://cnb.cx/SubscribeCNBCclassic About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more. Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: http://cnb.cx/LikeCNBC Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC #CNBC #Viagra How Viagra Made Pfizer Billions Before Generics

Published 2019-05-01 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.